Year: 2022

Sorrento Announces Significant Positive Pivotal Trial Results as Assessed by an Independent Review Committee (IRC) With Matured Long-Term (Over Three Years) Follow-Up Data of Abivertinib for the Treatment of Advanced Non-Small Cell Lung Cancer (NSCLC)

eSight and Marathon Medical Corporation Partner to Provide Sight Enhancing Medical Devices to the U.S. Department of Veterans Affairs

This partnership brings eSight 4 availability to 1,298 VA centers nationwideTORONTO, Aug. 23, 2022 (GLOBE NEWSWIRE) -- Leading vision-enhancement platform,...

error: Content is protected !!